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ABSTRACT
 Thyroid hormone receptor (TR) is critical in many aspects of  metabolic control and 
development. TR acts as a transcription factor when bound to thyroid hormone (T3 and T4) to 
change gene expression of  thyroid hormone response elements (TREs). There are two main 
isoforms of  TR: TRα and TRβ. TR can shuttle into and out of  the nucleus via an importin or 
exportin-mediated pathway through the nuclear pore complex. The importin or exportin binds 
to TR at a nuclear localization sequence (NLS) or a nuclear export sequence (NES) to transport 
TR into or out of  the nucleus, respectively. A well characterized nuclear export pathway is the 
cooperative CRM1/calreticulin-mediated export pathway. However, TRα and TRβ also can 
follow a CRM1-independent pathway for nuclear export.  The main objective of  this research 
was to determine if  exportin 5 (XPO5) or RanBP17 mediate the export of  TR via a CRM1- 
independent nuclear export pathway. XPO5 has been characterized as an export factor for 
microRNAs, as well as for the androgen receptor. RanBP17 has only been characterized as a 
potential exportin based on CRM1 homology. To determine if  XPO5 mediates TR’s export by 
the latter pathway, XPO5 was over-expressed in HeLa cells. The distribution and transcriptional 
activity of  GFP-tagged TRα or TRβ was analyzed by fluorescence microscopy and CAT ELISA, 
respectively. TR is primarily nuclear at steady-state, but TR had a more cytoplasmic distribution 
when XPO5 was overexpressed. In addition, CAT reporter gene expression under control of  a 
thyroid hormone response element was markedly decreased when XPO5 was over-expressed, 
indicating less TR was present in the nucleus. TR has multiple nuclear export sequences (NESs) 
in the ligand-binding domain. We tested the helix 12 NES (NES-H12) and the NES located in 
the 3rd and 6th helices (NES-H3/H6) on their interactions with XPO5. The NES-H12 construct 
had a more cytoplasmic distribution when XPO5 was over-expressed, suggesting that XPO5 
utilizes NES-H12 during export.  We also over-expressed RanBP17 in HeLa cells and analyzed 
any changes in distribution of  GFP-TRα or TRβ, when analyzed by fluorescence microscopy 
and CAT ELISA, respectively.  Our microscopy results suggest thatRanBP17 facilitates nuclear 
export of  TRβ1 but not TRα, while the CAT ELISA results were inconclusive.  In conclusion, 
our results suggest that XPO5 can mediate TR nuclear export via the NES located in helix 12 of  
the ligand binding domain. Further, RanBP17 may play a role in nuclear export of  TRβ; 
however, replicate experiments are required to confirm this finding. Investigation of  the role of  
other exportins, such as RanBP16/XPO7, is needed to fully characterize the multiple export 
pathways followed by TR. Further insight gained from the regulation of  nuclear export of  TR 
will ultimately enhance understanding of  regulation of  thyroid hormone-responsive gene 
expression and the role of  TR in growth and development.
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INTRODUCTION
OVERVIEW
 Thyroid hormone receptors (TR) are proteins that are members of  the nuclear receptor 
(NR) superfamily.  There are two main isoforms of  TR: thyroid hormone receptor alpha (TRα) 
and thyroid hormone receptor beta (TRβ).  These transcription factors regulate gene expression 
by binding to their respective ligands and to target genes in the nucleus. Nuclear receptors move 
from the cell cytoplasm into the nucleus through the nuclear pore complexes (NPC). This process 
of  moving in and out of  the nucleus is called nucleocytoplasmic shuttling. There are two main 
signals for proteins to be imported or exported from the nucleus: nuclear localization sequences 
(NLS) and nuclear export sequences (NES).  These signals act like a zip code for sending a 
protein to a specific location inside the cell (Weis, 1998). Highly conserved NES have been 
characterized for TRα.  These NES are located at the 12th helix (NES-H12) and between the 
3rd and 6th helices (NES-H3-H6) (Mavinakere et al., 2012).  Protein movement into and out of  
the nucleus through the NPC is directed by other proteins called importins and exportins, 
respectively. One export pathway that is well characterized and used by many NRs is the CRM1-
dependent pathway. CRM1 is characterized as an exportin that binds to a leucine-rich NES on 
the NR (Grespin et al., 2008).  TR has also been described as using a CRM1-independent export 
pathway.  The specifics of  which exportins are used by TR remain ill-defined.  TR is known to be 
very important in many biological processes, such as metabolic control, heart rate control, and 
development.  Disregulation of  TR can also cause cancer and disease.  By understanding how 
TR nuclear export is regulated, insight can be gained on how to treat TR-associated diseases.
NUCLEAR RECEPTORS
 Nuclear receptors (NR) are proteins that act as transcription factors.  There are at least 50 
NRs already identified, with over 100 known to exist (McKenna and O’Malley, 2002; McKenna 
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et al., 1999).  The NR superfamily is the largest known family of  metazoan transcription factors 
(McKenna et al., 1999).  To be a member of  the NR superfamily, each NR must have the 
following domains: an amino-terminal activation domain, DNA-binding domain, hinge region, 
and a carboxyl-terminal domain containing a ligand-binding region.  Each NR also has two 
activation functions, AF-1 in the amino-terminal domain and AF-2 in the carboxyl-terminal 
domain (McKenna and O’Malley, 2002).  Within the NR superfamily, there are three types.  
Type I NRs are the classical steroid receptors, Type II include the thyroid hormone receptor 
(TR), and Type III include recently characterized receptors, also called orphan receptors.  Unlike 
Type I NRs, Type II NRs can bind to DNA in the absence of  their ligand and act as repressors 
that silence their target gene (McKenna et al., 1999).  When unbound to their ligand, Type I NRs 
are sequestered by heat shock proteins (hsp70, hsp90) and immunophilins to help control the 
steroid signal (Kumar et al., 2006).
 Depending on whether an NR is bound to its ligand or not, the NR can have a different 
subcellular localization.  When ligand-bound, all NRs are localized in the nucleus to act as 
transcription factors.  Within the nucleus, the active NRs congregate in ‘nuclear foci’ (Kumar et 
al., 2006).  However, when the ligand is not present, intracellular NRs can be localized to the 
nucleus, the cytoplasm, or across the whole cell uniformly.  For example, when glucocorticoid 
receptor (GR) and androgen receptor (AR) are not bound to their respective ligands, they have a 
primarily cytoplasmic distribution, while the mineralocorticoid receptor (MR) is located 
throughout the cell.  In contrast, the progesterone receptor (PR) and estrogen receptor (ER) 
remain in the nucleus, even when their ligands are absent.  Other types of  NRs have recently 
been identified as localizing to the plasma membrane and mitochondria (Kumar et al., 2006).  
Within the superfamily, all of  the NRs are specific to certain pathways and tissue types.  
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Therefore, even though there are similarities in homology across the superfamily, each NR needs 
to be studied individually to fully understand the signaling process.
THYROID HORMONE
	 The thyroid hormone (TH) is a key player in metabolism and growth in many different 
cell types.  The process of  producing thyroid hormone occurs along the hypothalamus-pituitary-
thyroid axis and is regulated by negative feedback loops (Yen, 2001).  The hypothalamus releases 
thyrotropin-releasing hormone (TRH), which goes to the anterior pituitary gland causing the 
release of  thyroid-stimulating hormone (TSH).  TSH travels to the follicular cells of  the thyroid 
gland, where thyroid hormone is released at large across the body (Waung et al., 2012).  There 
are two types of  TH, triiodothyronine (T3) and thyroxine (T4), which are structurally 
homologous except for a fourth iodine on T4.  T3 is the active form of  the hormone, and binds 
with a ten-fold greater efficiency to TRs than T4 (Oetting and Yen, 2007).  However, T4 is the 
pro-hormone that is predominantly circulating within an organism (Waung et al., 2012).  T3 is 
created from the pro-hormone T4 through deiodinating enzymes D1 and D2 (Visser et al., 2007). 
	 Originally, it was thought that TH moves into the target cell through diffusion, like 
transport of  steroids, but recent research indicates otherwise.  The majority of  TH is transported 
across the plasma membrane by specific membrane transport proteins and non-amino acid 
specific transporters (Waung et al., 2012).  Some of  the specific membrane transport proteins 
previously characterized are OATP1C1, MCT8, and MCT10.  OATP1C1 is localized in the 
brain, while MCT8 is seen across tissue types, most prominently in the liver and heart, and 
MCT10 is also seen across tissues, concentrated mostly in the intestine, kidney, liver, and placenta 
(Visser et al., 2007).  
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 Once in the nucleus of  the cell, TH can bind to the thyroid hormone receptor (TR) and 
change transcription patterns of  specific genes.  When TH binds to TR, TH causes a 
conformational change in helix 12 of  the ligand-binding domain of  TR, which changes how TR 
can interact with thyroid hormone response elements (TREs) in the DNA (Oetting and Yen, 
2007). Usually if  TR is unbound to TH, TR acts as a corepressor to transcription.  In contrast, 
when TH is bound, TR in most cases enhances transcription.  Other factors, including 
corepressors (N-CoR and SMRT) and the extent of  acetylation of  histones contribute to gene 
expression or repression as well (Lonard and O’Malley, 2007).
	 While TH can affect genomic transcription through the classical mechanism by binding 
to TR, TH is also involved in other signaling cascades.  TH plays a role in lipid metabolism and 
homeostasis by activating rate limiting enzymes involved in fatty acid hepatic synthesis and 
triglyceride esterification (Cordeiro et al., 2013).  While the classical mechanism is the focus of  
this thesis, it is important to remember the TH has far reaching effects within an organism, and 
therefore must be regulated closely in multiple cell types.  
THYROID HORMONE RECEPTOR
 The thyroid hormone receptors (TR) are proteins that have two main isoforms TRα and 
TRβ.  These two TRs are encoded by the genes THRA and THRB on human chromosomes 
17q11 and 3p24, respectively (Jazdzewski, 2011).  Through alternative splicing, six specific 
isoforms are made: TRα1, TRα2, TRα3, TRβ1, TRβ2, and TRβ3.  TRs are activated when 
they are bound to both T3 and specific TREs in the promoter region of  a gene.  However, TRα2 
and TRα3 are unable to bind to T3 (Jazdzewski, 2011).  TRα2 is also called c-erbAα-2 and may 
act antagonistically to inhibit TH action (Yen, 2001).  TRs are tissue specific in their expression.  
For example, TRα1 is most predominantly expressed in skeletal muscle and brown fat, while 
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TRβ1is seen most commonly in the brain, kidney, and liver (Yen, 2001).  TR expression is 
widespread throughout the body, but certain isoforms have highly specialized tissue types.  For 
instance, TRβ2 is only seen in the anterior pituitary gland and parts of  the hypothalamus (Yen, 
2001).
	
DOMAINS
	 TR has multiple domains that include the N-terminal domain, the DNA-binding domain 
(DBD), the hinge domain, and the carboxyl-terminal ligand-binding domain (LBD).  While the 
N-terminal transactivation domain varies between isoforms, the DBD is highly conserved (Cheng 
et al., 2010).  Each domain has a specialized function.  The N-terminal domain harbors the 
amino-terminal activation function (AF-1), which aids in transcription activation.  The DBD 
contains two zinc finger motifs, which bind TREs and are conserved across NRs (Cheng et al., 
2010).  
 The hinge region originally was thought to function solely as a domain to separate the 
DBD and LBD.  However, previous research has shown that TR has a nuclear localization signal 
(NLS) in the hinge region, along with another NLS only present in the N-terminal domain of  
TRα1 (Mavinakere et al., 2012).  A NLS is a sequence that tags a particular protein to get 
transported into the nucleus.  Likewise a nuclear export sequence (NES) tags a protein for export 
from the nucleus.  While many NRs, including the glucocorticoid receptor and androgen 
receptor, have their NLS in the DBD or LBD domain, surprisingly, TR has multiple NESs 
located in the LBD region, one at helix 12 and two more NES located between helix 3 and helix 
6 (Mavinakere et al., 2012).  
	 The LBD and DBD also have regions of  dimerization.  TR forms either a homodimer, or 
a heterodimer with the retinoid X receptor (RXR) (Oetting and Yen, 2007).  Many members of  
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the NR superfamily can heterodimerize with RXR.  When RXR is present, it allows for more 
nuanced transcriptional activity (Yen et al., 2006), through the ligand-sensitivity of  RXR (Zhang 
et al., 1992).  The LBD is also bound to heat shock proteins and other regulatory proteins when 
not bound to T3 (McKEnna et al., 1999).  
 Each of  the isoforms of  TR has a slightly different amino acid sequence, and therefore, a 
slightly different structure.  The THRA gene creates two different mRNAs and proteins through 
alternative splicing.  TRα1 and TRα2 have the same 1-370 amino acid residues but differ in their 
LBDs after amino acid 370 (Oetting and Yen, 2007).  Alternatively, the THRB gene has 
alternative promoter regions, which create two separate proteins, TRβ1 and TRβ2.  TRβ1 and 
TRβ2 are structurally identical except for their N-terminal domains (Oetting and Yen, 2007).  
Since all the isoforms are slightly different structurally, and each domain has multiple functions, it 
is imperative to characterize each TR isoform individually, while looking at similarities across the 
group.
LOCALIZATION AND SHUTTLING
 Under normal physiological conditions, the majority of  TR is localized to the nucleus of  
the cell.  TRα has an approximately 90% nuclear localization, while TRβ has a slightly more 
cytosolic distribution, with approximately 85% nuclear localization.  This partially cytosolic 
distribution of  TR lead researchers to investigate a seemingly constant flux of  TR into and out of 
the nucleus, also called shuttling (Baumann et al., 2000; Bunn et al., 2001).  This equilibrium is a 
balancing act between nuclear import, nuclear retention, and nuclear export.
 Transport of  proteins into and out of  the nucleus through the nuclear pore complexes 
(NPC) is mediated by transport receptors (Gwizdek et al., 2004). The NPC is made up of  
proteins called nucleoporins, which span the nuclear envelope to create an aqueous channel 
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between the nucleus and cytoplasm (Brownawell and Macara, 2002). Small molecules (<60 
daltons) can diffuse through the NPC, but large molecules move through facilitated by transport 
receptors that are members of  the karyopherin β family (Gwizdek et al., 2004).  The transport 
receptor and cargo can interact either directly or facilitated by substrate-specific adaptor proteins 
(Calado et al., 2002). Transport receptors fall into two main categories, importins and exportins, 
based on their movement of  cargo with an NLS or NES into or out of  the nucleus (Grespin et 
al., 2008).
 Characteristics of  the karyopherin β family include a RanGTPase-binding motif, direct 
binding with nucleoporins, and cargo recognition in a Ran-dependent manner (Brownawell and 
Macara, 2002). The asymmetry of  RanGTP binding to importins and exportins aids in the 
compartmentalization of  cargo and the directionality of  transport. In nuclear import, RanGTP 
facilitates disassociation of  importins and cargo in the nucleus, while in nuclear export, RanGTP 
facilitates binding of  exportins to their cargo (Brownawell and Macara, 2002). The complex 
moves through the NPC, RanGTP is converted to RanGDP by RanGTPase activating protein 
(RanGAP), and the protein complex dissociates (Calado et al., 2002).
	
IMPORT
 The classical mechanism of  nuclear import involves a heterodimer of  importin α and 
importin β.  Importin α binds to a protein containing a classical NLS (c-NLS).  Then importin β 
binds to importin α and mediates transport of  the trimer through the NPC (Kakuk et al., 2008).  
Once inside the nucleus, the complex disassociates when Ran-GTP binds to importin β.  Then 
an exportin (CAS) bound to Ran-GTP transports importin α back out of  the nucleus.  Hydrolysis 
of  Ran-GTP into Ran-GDP causes CAS to disassociate from the complex, leaving CAS in the 
cytoplasm, and the Ran-GDP is recycled to the nucleus (Goldfarb et al., 2004).  Besides the 
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classical importin α/β pathway, there are pathways that use other members of  the karyopherin β 
family.  These karyopherins can bind to a variety of  NLSs.  Some NLSs contain basic residues, as 
seen in core histones, and are rich in arginines and glycines, like RNA-binding proteins.  For 
other NLSs with relatively large domains that lack basic residues, the three dimension protein 
structure seems critical (Pemberton and Paschal, 2005).  A wide variety of  cargo can be 
transported into the nucleus, including NRs, through the importin α/β pathway (Kumar et al., 
2006).  Similarly, NRs can also use a variety of  importins.  For example, the glucocorticoid 
receptor can use its NLS-1 to be transported by the importin α/β, importin 7, or importin 8 
pathways (Pemberton and Paschal, 2005; Kumar et al., 2006).  Furthermore, we have shown 
recently that TR can use importin 7 or the importin α3/β1 pathways to be transported from the 
cytoplasm into the nucleus (Parente, 2010) (Figure 1A).
EXPORT 
 The other side of  the balancing act between transport into and out of  the nucleus, is 
nuclear export of  NRs by the karyopherin β superfamily.  Most of  the functions of  the 
approximately 22 identified karyopherin β family members remain unknown. Nevertheless, two 
of  the best characterized receptors are Exportin-t and CRM1. Exportin-t facilitates transport of  
tRNAs out of  the nucleus by recognizing correct tertiary structure. Exportin-t selects for mature 
over premature tRNAs, but has no preference for specific tRNAs (Calado et al., 2002). CRM1 is 
a general transport receptor, meaning that it can export many different proteins. Cargo binds to a 
leucine-rich NES on the cargo to facilitate transport (Brownawell and Macara, 2002).  
Leptomycin B is a known specific inhibitor of  CRM1 that has greatly facilitated studies of  this 
exportin and helped reveal CRM1 independent export pathways (Calado et al., 2002) (Figure 
1B).  Exportin 5 (XPO5) is transport receptor that has been characterized based on its role in 
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Figure 1: TR nuclear import and export
A. Left is classical import model, where importin α3 is used as an adaptor protein with importin 
β1 to mediate nuclear import of  TR.  Right is an alternative pathway were nuclear import of  
TR is mediated by importin 7.  B. Left is classical export model, where calreticulin binds to TR 
and CRM1 to mediate export out of  the nucleus. Right represents CRM1 independent 
pathways, which have yet to be characterized for TR. 
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microRNA (miRNA) export. Another recently discovered protein that is thought to have 
transport receptor characteristics is the Ran Binding Protein 17 (RanBP17).  These two proteins 
(XPO5 and RanBP17) will be the focus of  this thesis. 
The Discovery of  XPO5
 XPO5 was found during a database screen using the CRM1 sequence to identify other 
general export receptors (Brownawell and Macara, 2002). Through sequence analysis, a human 
clone (KIAA1291) was discovered with an incomplete open reading frame. Using the clone, 5' 
primers were designed to use in 5' rapid amplification of  cDNA ends (RACE) to create a 
complete open reading frame (Brownawell and Macara, 2002). The resulting mature protein was 
named XPO5, because it was later shown to transport protein cargo from the nucleus to the 
cytoplasm, and it was fifth member of  the mammalian karyopherin β family to be characterized 
(Brownawell and Macara, 2002). 
 Initially to see if  XPO5 was a transport receptor, XPO5 was tested for its ability to bind 
to RanGTP and nucleoporins. A yeast two-hybrid assay showed that XPO5 could interact with 
Ran, specifically the NH2-terminal region of  XPO5 (Brownawell and Macara, 2002). Studies 
showing a direct interaction in vitro between Ran-GTP and XPO5 using GST-tagged Ran 
confirmed these results (Brownawell and Macara, 2002). XPO5 can also associate with the 
cytosolic nucleoporin Can/Nup214 and NPC basket nucleoporin Nup153, which confirmed that 
XPO5 is an exportin of  the karyopherin β family (Brownawell and Macara, 2002).  This 
association of  XPO5 with nucleoporins is independent of  RanGTP as seen in co-
immunoprecipitation assays with XPO5 and RanQ69L, a Ran mutant locked in the GTP-bound 
form (Brownawell and Macara, 2002). Subsequent experiments revealed that XPO5 is conserved 
across plant, animal, and fungal kingdoms except for nematodes (Murphy et al., 2008). Another 
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set of  investigations concluded that even though XPO5 is conserved from budding yeast to 
humans, there are some differences in cargo preferences (Shibata et al., 2006).
Cargo of  the general transport receptor XPO5
 XPO5 was first shown to export tRNA, and tRNA bound to eukaryotic elongation factor 
1A (eEF1A), in a RanGTP-dependent manner (Calado et al., 2002). Through microinjection 
experiments, it was found that eEF1A localized in the cytoplasm when XPO5 was added (Calado 
et al., 2002). These assays involved translating eEF1A in the presence of  35S-methionine in vitro in 
rabbit reticulocyte lysate then injecting it into the nuclei of  Xenopus laevis oocytes (Calado et al., 
2002). Subsequent studies confirmed that XPO5 facilitates transport of  interleukin enhancer 
binding factor (ILF). Brownawell and Macara (2002) created mutant versions of  ILF and tested 
their ability to bind to XPO5 using a 32P-labeled dsRNA probe. It was concluded that transport 
depended on the double-stranded RNA binding domain (dsRBD) of  XPO5 (Brownawell and 
Macara, 2002). Subsequent analysis of  the dsRBD showed that XPO5 bound to its cargo’s 
dsRBD in a strictly sequence independent manner (Bohnsack et al., 2004). 
	 Further analysis of  RanGTP competition experiments led to the discovery that 
microRNAs (miRNAs) are a cargo of  XPO5 (Lund et al., 2004). miRNAs are part of  a conserved 
system of  RNA-based gene regulation at the post-transcriptional level. miRNAs are first made as 
imperfect RNA hairpins (pri-miRNAs) in the nucleus that are spliced by the RNase III Drosha 
into 60-80 nucleotide hairpin structures called pre-miRNAs (Yi et al., 2003; Bohnsack et al., 
2004), and then exported to the cytoplasm. These pre-miRNAs are processed into short (~22 
nucleotides) double stranded miRNAs by the RNase Dicer, and are then incorporated into the 
RNA-induced silencing complex (RISC). Through complementary base pairing the miRNAs 
lead the RISC to mRNAs targeted for degradation or translational repression (Yi et al., 2003). 
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XPO5 was also tested for direct interaction with 32P-pre-miRNA to determine if  XPO5 can bind 
pre-miRNAs, because previous to discovering XPO5, the export pathway of  pre-miRNAs was 
unknown (Lund et al., 2004). As shown in short interfering RNAs (siRNAs) and RNA 
interference (RNAi) studies, XPO5 can interact directly with pre-miRNAs and is a key player in 
miRNA biogenesis (Lund et al., 2004; Leisegang et al., 2012). XPO5 not only acts as a nuclear 
export factor for miRNA, it also inhibits degradation of  bound pre-miRNA by nucleases (Okada 
et al., 2009). Furthermore, when XPO5 expression is inhibited through siRNA, pre-miRNA is 
unable to suppress target mRNA expression. Thus, pre-miRNA export is dependent on XPO5 
(Yi et al., 2003).
Structure of  XPO5
  The structure of  XPO5 was determined by X-ray crystallographic analysis of  XPO5 
and signal information from crystals containing pre-miRNA 5-bromo-oxyuracil derivatives 
(Okada et al., 2009). Okada et al. (2009) modeled 1,082 XPO5 residues to ultimately find that 
the XPO5, RanGTP, and pre-miRNA complex is an ellipsoid with dimensions of  65Å by 80Å, 
by 110Å. XPO5 forms a baseball mitt-like structure, with a tunnel-like structure the cargo can 
pack (Okada et al., 2009). The export motif  of  pre-miRNA that is recognized by XPO5 is called 
a minihelix, which consists of  a double stranded stem of  at least 14 nucleotides long. The 5' end 
of  the pre-miRNA is base paired, and the 3' end has a short unpaired section of  nucleotides, 
which can tolerate imperfect base pairing and bends (Gwizdek et al., 2004). When pre-miRNA is 
the cargo of  XPO5, the free two-nucleotide 3' end is inserted into the base of  the tunnel and 
interacts with HEAT repeats 12-15 of  XPO5. The 3' overhang is stabilized by forming salt 
bridges and hydrogen bonds with the amino acids of  XPO5 (Okada et al., 2009). Structural 
studies also showed that binding of  the pre-miRNA to XPO5 is a sequence-independent process, 
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and only depends on the length of  the double-stranded stem and the two-nucleotide long 3' 
overhang (Okada et al., 2009). 
RanBP17  
 Ran binding protein 17 (RanBP17) was first discovered in 2000 when Koch et al. were 
investigating a common break site and translocation area on chromosome eight, which is involved 
with acute lymphoblastic leukemia.  Parts of  the RanBP17 gene were isolated and sequenced, 
and Koch et al.’s results showed that RanBP17 shared 100% homology with the KIAA0745 
gene, except for a 540bp insertion at position ~800 and a few differences in the 5' end region.  
Even though the initial experiments were done with murine genes, they showed a greater than 
67% homology to the human gene equivalent (Lee et al., 2010). Structural analysis revealed that 
RanBP17 is a member of  the importin β superfamily, because it has an importin β N-terminal 
domain (Koch, et al., 2000).  RanBP17 and exportin 7 (also called RanBP16) are evolutionarily 
distinct from the rest of  the NRs in the importin β superfamily. RanBP17 is thought to have 
evolved later, since it has only been seen in vertebrates (Kutay, 2000).  In comparison to the 
importin β superfamily as a whole, RanBP17 has the highest sequence homology to CRM1.  The 
characteristic importin β N-terminal domain is a small section within the larger CRM1 
homology (Lee et al., 2010).  Even though the cargo of  RanBP17 has yet to be identified, with 
this sequence homology, it has been hypothesized to act like a nuclear transport receptor (Kutay, 
2000).
LINK TO DISEASE:
 Thyroid disease is one of  the leading endocrine diseases worldwide, affecting almost a 
half  billion people (Oetting and Yen, 2007).  Serious risk for thyroid disease is caused by 
improper maintenance and function of  thyroid hormones (T3 and T4), which regulate large 
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areas of  gene expression through TRs.  Localization of  NRs play a key role in maintaining the 
normal function of  cells.  Mutations or post translational changes in NRs can cause excessive 
growth and cancer, especially in organs that have high NR activity like breast, ovary, pancreas, 
intestine, prostate, and lung (O’Malley and Kumar, 2009).  For example when AR is mutated, it 
mislocalizes causing another steroid receptor (coactivator 1) to mislocalize, which has been linked 
to prostate cancer (Nazareth et al., 1999).  Mutations and mislocalization of  TR can lead to 
resistance to thyroid hormone, metabolic abnormalities, and thyroid cancer (Cheng et al., 2010). 
 Specific to TR, certain isoforms can also alter subcellular localization, such as v-ErbA, the 
oncogenic version of  TR, found in chicken erythroblasts associated with the avian 
erythroblastosis virus (Oetting and Yen, 2007).  v-ErbA dimerizes with RXR to change the 
subcellular localization of  TRα (Bonamy et al., 2005).  Mutations in TRβ also show deleterious 
effects.  To date, 124 different mutations have been found in TRβ, with one well-characterized 
(Pro453His mutation), which were described to cause resistance to thyroid hormone (RTH) 
(Cheng et al., 2010).  While most patients are heterozygotes for the TRβ mutation with mild 
cases of  RTH, there was one case of  homozygous mutated TRβ, where the individual displayed 
a severe RTH phenotype and died young (Ono et al., 1991).  
 Exportins have also been shown to be involved with disease.  While little information is 
known about RanBP17, recent studies of  miRNA biogenesis and XPO5 have led to discoveries 
linking XPO5 misregulation to tumorigenesis and disease. For example, adenovirus VA1 has been 
shown to use the XPO5 export pathway. VA1 can competitively inhibit other XPO5 cargo by 
saturating XPO5 for export. This saturation of  XPO5 leads to the inability to export miRNAs 
and alters post-transcriptional gene regulation by miRNAs (Perron and Provost, 2009). Even 
though there is no direct link between cancer and XPO5, if  miRNA levels are lowered by 
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expression of  XPO5, then the individual’s risk for developing cancer increases. Through genetic 
screening and epigenetic association studies of  patients with variants of  XPO5 and breast cancer,  
researchers found a link between changes in miRNA expression based on XPO5 levels and 
tumorigenesis (Leaderer et al., 2011). In another study, XPO5 was also shown to indirectly 
modulate apoptosis in cells, because XPO5 was able to export Fas-associated death domain 
protein (FADD) to the cytoplasm (Screaton et al., 2003).
	 Down regulation of  miRNAs has been seen in many malignancies (ovarian, breast, and 
prostate), which suggests that miRNAs may be able to suppress tumorigenesis (Melo and Esteller, 
2011). Frameshift mutations in exon 32 were found in the XPO5 gene in two MSI colon cancer 
cell lines and primary tumors. The mutant sequence encodes a truncated form of  XPO5, which 
makes it unable to associate with pre-miRNA and export it into the cytoplasm (Melo and Esteller, 
2011). Even in cells heterozygous for this mutation, there is less pre-miRNA exported and 
processed. This leads to less mature miRNA in the cytoplasm, and a greater chance of  
tumorigenesis. To provide further evidence for this conclusion, Melo and Esteller (2011) were 
able to rescue pre-miRNA export and processing by restoring XPO5 protein levels in the cells 
already producing the truncated form of  XPO5. These rescued cells then showed tumor 
suppressing features.
THESIS OBJECTIVE:
 Since TR mediates the cellular response to T3 and T4, TR is extremely important in 
development and disease.  To maintain correct levels of  TR inside the nucleus, nuclear export of  
TR is also critical for homeostasis.  Mislocalization of  nuclear receptors to the cytoplasm is 
related to thyroid diseases and cancer.  Additionally, mutated TRs are involved in thyroid 
metabolism, and promotion of  oncogenetic activities as seen through mislocalization of  TR by v-
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ErbA, lung carcinomas, some skin carcinomas, lymphomas, lymphocytic (Bcl3) or acute myeloid 
leukemias, (Bonamy et al., 2005; O’Malley and Kumar, 2009).  When TR is exported from the 
nucleus, TR cannot bind to DNA, and therefore TR cannot regulate gene expression.  Currently 
there are both CRM1-dependent and CRM1-independent export pathways that facilitate 
transport of  TR from the nucleus to the cytoplasm (Grespin et al., 2008; Mavinakere et al., 
2012).  By characterizing CRM1-independent export pathways, like XPO5 and RanBP17, 
further insight into T3-responsive gene transcription and regulation will be attained.  These 
findings may have further implications on the regulation of  other members of  the nuclear 
receptor superfamily as well.   
	 The overall objective of  this thesis research was to examine whether exportin 5 or 
RanBP17 are used in the nuclear export of  TR, through over-expression of  exportin 5 or 
RanBP17 in transfected cultured HeLa cells.  Prior fluorescence recovery after photobleaching 
(FRAP) assays in our lab provide preliminary evidence that exportin 5 mediates the CRM1-
independent nuclear export pathway for TR (Subramanian, 2012).  In addition, we recently 
characterized a NES in helix 12 and up to two CRM1-independent NESs in the ligand-binding 
domain between helix 3 and helix 6 (Mavinakere et al., 2012).  Thus, to determine which 
CRM1-independent NES in TR is recognized by exportin 5, TR constructs, which only have one 
of  the two CRM1-independent NESs were analyzed.  Even though little is known about the 
cargo of  RanBP17, it was hypothesized that RanBP17 can also mediate TR export into the 
cytoplasm, based on sequence homology with CRM1.
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METHODS
PLASMIDS  
 The plasmid pGFP-TRα1 encodes green fluorescent protein (GFP)-tagged, full-length rat 
TRα1, while pGFP-TRβ1 encodes the full length GFP-tagged human TRβ1 (Mavinakere et al., 
2012). The nuclear export sequence expression plasmids encoding GFP-GST-GFP-Hinge-
LBDΔ269-410 (NES-H3/H6) and GFP-GST-GFP-NES-H12-Hinge mutant TRα1 plasmids 
were described previously (Mavinakere et al., 2012).  
 The plasmid pKmyc-Exp5 encodes a Myc-tagged functional exportin-5 protein and was 
acquired from Addgene (Addgene #12552) (Brownawell and Macara, 2002).  The HA-tagged 
RanBP17 expressioin plasmid was a gift from C. Smas (University of  Toledo College of  
Medicine, Ohio) pCMV-Myc (#631604) was acquired from Clontech, while pCMV-HA 
(#K6003-1) was obtained from BD Biosciences.  The pCAT®3-Basic Vector (#E1871) was 
acquired from Promega, while the tk-TREp-CAT plasmid was a gift from R. Evans (Salk 
Institute for Biological Studies).  The tk-TREp-CAT plasmid is a TRE linked with the herpes 
simplex virus thymidine kinase (tk)-chloramphenicol acetyltransferase (CAT) fusion gene reporter. 
These plasmids were subcloned into DH5α cells, allowed to amplify, then purified with a Qiagen 
midi-prep kit using the manufacturer’s protocol.  The amount of  DNA was quantified using a 
ND-1000 spectrophotometer (NanoDrop Technologies).  
CELL CULTURE
 HeLa cells were cultured under Biosafety level II conditions using a Labconco cabinet.  
HeLa cells were grown at 37°C under 5% CO2 and 98% humidity in a ThermoScientific 
incubator to 70-90% confluency.  Cells were cultured in filter-capped flasks (Nunc) in Minimum 
Essential Medium (Gibco), enhanced with 10% fetal bovine serum (FBS) (Invitrogen).  The 
17
antibiotics penicillin (100 units/mL) and streptomycin (100µg/mL) were intermittently added to 
the growth medium.  
 To seed 6 well plates with glass coverslips, HeLa cells were first washed with D-PBS (D-
PBS: 0.10g KCL, 0.10g KH2PO4, 4.00g NaCl, and 1.08g Na2HPO4·7H20 in 500 mL of  H2O).  
Cells were dislodged from the flask by incubating them with 0.25% trypsin for 2 minutes at room 
temperature, aspirating off  the trypsin, and then incubated at 37°C for a subsequent 2 minutes.  
Cells were then resuspended in Minimum Essential Medium with FBS, counted using a 
hemocytometer, and seeded at 2.5-3.0 x 105 cells per well in 2mL of  medium on a coverslip 
(Fisher) in a 6-well plate (Costar).  The HeLa cells were incubated at 37°C for approximately 24 
hours, until the cells reached about 70% confluency.  
TRANSIENT TRANSFECTION
 Expression plasmids were transfected into HeLa cells to visualize the subcellular 
localization of  the fluorescently-tagged proteins by fluorescence microscopy. Cotransfections of  
two or more plasmids were carried out to introduce and simultaneously overexpress multiple 
proteins within the cells.  For transient transfections, 2µg of  total plasmid DNA was diluted in 
250µL of  Opti-MEM I Reduced Serum Medium (Invitrogen).  For cotransfections, the 2µg of  
plasmid DNA was split between the two plasmid types.  For example, when transfecting with 
TRα1 and pKmyc-Exp5, 0.5µg of  TRα1 and 1.5µg of  pKmyc-Exp5 were added.  A second 
solution (250µL total) was made of  4µL of  Lipofectamine 2000 Reagent (Invitrogen) in 246µL 
Opti-MEM I Reduced Serum Medium.  The two mixtures were incubated separately for 5 
minutes, before they were combined and incubated for 20 minutes.  Then, 500µL of  the 
combined solution was added to each seeded coverslip in the 6-well plate.  After a 7 to 8 hour 
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incubation at 37°C, the Opti-MEM media was replaced with 2 mL of  Minimum Essential 
Medium with FBS per well.    
FIXATION AND IMMUNOFLUORESCENCE
 Approximately 24 hours post transfection, the HeLa cells were fixed and stained for 
visualization and analysis by fluorescence microscopy.  The Minimum Essential Medium with 
FBS was removed, and the cells were washed three times with 2mL of  D-PBS for 15 seconds.  
The cells were fixed with a 3.7% formaldehyde solution in D-PBS for 10 minutes in a fume hood 
(Fisher Hamilton).  After the formaldehyde was disposed of  in the designated waste container, the 
cells were washed with 2mL D-PBS three more times for 5 mins.  Cells were permeabilized with 
0.2% Triton-X in D-PBS solution for 5 minutes, then washed three more times with 2mL D-PBS 
three times per well for 5 minutes.  The coverslips were inverted on 30µL of  an antibody mix of  
1:500 dilution of  primary antibody, 1.5% normal goat serum (#PCN5000 Invitrogen), and D-
PBS.  The primary antibody used for XPO5 was an anti-Myc antibody (c-Myc mouse 
monoclonal antibody, Clontech, Cat#631206, Lot#1104389A) and for the HA-tagged proteins 
an anti-HA antibody was used (rabbit polyclonal antibody to HA tag, Abcam #ab9110, Lot# 
GR20600-3).  The coverslips were flipped using tweezers onto parafilm, which was suspended in 
a humidified storage chamber for 1.5 hours.  The humidified chamber consisted of  parafilm 
suspended with tape above a damp paper towel.  At the end of  the incubation, the coverslips 
were flipped back into the 6-well plates face up, using tweezers.  After washing the wells three 
times with 2mL D-PBS for 5 minutes, the coverslips were inverted, using tweezers, on 30µL of  an 
antibody mix of  1:500 dilution of  secondary antibody, 1.5% normal goat serum (#PCN5000 
Invitrogen), and D-PBS.  The secondary antibody for Myc-tagged protein assays was CY3 
conjugated Goat Anti-Mouse IgG(H+L) (ZyMax, Invitrogen #81-6515, Lot: 382943A), while 
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Texas Red Anti-Rabbit IgG(H+L) (Vector Laboratories, TI-1000, Lot: S0504) was used for HA-
tagged protein assays.  The coverslips were incubated for 45 minutes in a humidified chamber in 
the dark.  Next, the coverslips were flipped back into the 6-well plate, and washed again three 
times with D-PBS for 5 mins each time.  After draining the excess liquid by touching the edge of  
the coverslip to a KimWipe (Kimberly-Clark), the coverslips were mounted using GelMount with 
DAPI (2µL of  0.25µg/µL DAPI stock per 1 mL of  GelMount) onto glass slides (Fisherfinest, 
Fisher Scientific), using tweezers.  The slides were stored flat in a slide box at 4°C for 
approximately 24 hours before scoring.
FLUORESCENCE MICROSCOPY
 The mounted slides were analyzed with the Nikon Eclipse TE2000E fluorescence 
microscope (Sigma, Melville, NY) using the inverted 60x oil immersion objective.  Three filters 
were used to determine subcellular localization patterns.  The UV-2E/C light filter block was 
used to visualize the DAPI-stained nuclei.  The FITC (blue light) B-2E/C filter block excited the 
GFP-tagged TRα1and TRβ1 proteins, which fluoresced green.  The TRITC (green light) T-2E/
C filter block allowed visualization of  the fluorophore-conjugated secondary antibodies (anti-
Myc, anti-HA), which emit red fluorescence.  Pictures of  the cells were taken using a 
Photometrics Cool Snap HQ2 camera or a Nikon A1Rsi microscope Ti-E-PFS camera, with a 
40x water objective.  NIS-Elements 2.30 software and Adobe Photoshop CS were used to 
normalize and layer images.  Adobe Illustrator was used to construct figures, and Mac OS X 
Numbers was used to construct charts.
CELL SCORING WITH ANALYSIS
 Before cells were scored, they were blinded by another lab member to control for a 
scoring bias.  At least three trials of  three slides each, with a minimum of  100 cells scored per 
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slide, were conducted for each experimental group.  Transfections of  pGFP-TRα1 or pGFP-
TRβ1 with either pCMV-Myc, pmyc-Exp5, pCMV-HA, or pRanBP17 plasmids were scored into 
two categories: primarily nuclear, or nuclear and cytoplasmic.  Transfections with TRα1 NES 
expression plasmids, GFP-GST-GFP-Hinge-LBDΔ269-410(NES-H3/H6) and GFP-GST-GFP-
NES-H12-Hinge, and either pCMV-Myc or pmyc-Exp5, were categorized into four groups: 
nuclear, nuclear greater than cytoplasmic, whole cell, and nuclear less than cytoplasmic.  After 
the counts were complete, the slides were unblinded and statistical tests were performed.  
Statistical tests included averages, standard deviation, and standard error. 
CAT ELISA
 Chloramphenicol Acetyltransferase (CAT) Enzyme-linked Immunosorbent Assay (ELISA) 
was performed to quantify TR-mediated transactivation of  a CAT reporter gene, under control 
of  a TRE.  The CAT protein is only made in the presence of  TR, so the amount of  CAT protein 
produced correlates with the amount of  TR in the nucleus.  HeLa cells were seeded at 
approximately 7.0 x 105 cells per 100mm dish with 10mL of  Minimum Essential Medium with 
FBS.  After incubating for approximately 24 hours at 37°C, the cells were transfected with a total 
of  10µg of  plasmid DNA diluted in 1.25mL of  Opti-MEM I Reduced Serum Medium 
(Invitrogen).  Since these were cotransfections, the 10µg of  plasmid DNA was split between the 
plasmid types.  The pCAT®3-Basic Vector with pGFP-TRα1 control had 5µg for each plasmid, 
while each experimental group had 3 plasmids with 3.33µg of  each plasmid.  For example, when 
transfecting with TRα1 and pKmyc-Exp5 (XPO5 expression plasmid), 3.33µg of  pGFP-TRα1, 
3.33µg of  ptk-TREp-CAT, and 3.33µg of  pKmyc-Exp5 were added.  A second solution (1.25mL 
total) was made of  20µL of  Lipofectamine 2000 Reagent (Invitrogen) in 1.23mL Opti-MEM I 
Reduced Serum Medium.  The two mixtures were incubated separately for 5 minutes, before 
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they were combined and incubated for 20 minutes.  Then, 2.5mL were added to each seeded 
100mm dish.  After a 6 hour incubation at 37°C, the Opti-MEM media was replaced with 10 
mL of  Minimum Essential Medium with FBS per well.  Approximately 12-13 hours post-
transfection, the medium was replaced again with Minimum Essential Medium containing 10% 
charcoal-dextran stripped FBS.  Half  of  the 100mm plates (one of  each experimental category) 
were supplemented with 110 nM T3.  
 Approximately 24 hours post transfection, the media was aspirated off  in the Labconco 
biosafety cabinet, then plates were washed carefully three times with 5mL of  pre-cooled D-PBS.  
Next, the cells were prepared for ELISA according to the manufacturer’s protocol (Roche 
Applied Sciences).  In brief, cells were lysed by incubating them in 1.5mL lysis buffer with 
protease inhibitors on ice for 30mins. Subsequently, cells were scraped off  the plates, lysates were 
centrifuged for 10 mins at 4°C to remove any cellular debris, and protein concentration was 
determined using the ND-1000 spectrophotometer (NanoDrop Technologies).  The amount of  
protein was adjusted to 600µg per 500µL with lysis buffer.  The CAT protein working dilution 
was also prepared fresh for each experiment by first diluting a CAT stock solution in sample 
buffer, then creating working dilutions of  0, 0.125, 0.25, 0.5, and 1.0 ng of  CAT enzyme per 
milliliter.  
For the ELISA assay, 200µL of  either the blank (POD substrate), working CAT dilutions, 
or cell extracts were added to each well on the ELISA microplate, with two replicates per plate. 
The cell extracts were covered with foil and incubated at 37°C for 1 hour.  Then the extracts 
were removed, the microplate was washed 5 times with 250µL washing buffer for 30 seconds 
each, and the 200µL Anti-CAT-Digoxygenin (DIG) working dilution was added to each well.  
After incubating covered with foil for 1 hour at 37°C, the Anti-CAT-DIG was removed, the 
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microplate wells were washed 5 times with 250µL of  washing buffer for 30 seconds each, and 
200µL of  Anti-DIG-peroxidase (POD) working dilution was added to each well.  After another 1 
hour incubation covered in foil at 37°C, the Anti-DIG-POD was removed, the microplate was 
again washed 5 times with 250µL of  washing buffer for 30 seconds each, and 200µL of  POD 
substrate was added to each well.  The POD substrate was incubated at room temperature 
(15-25°C) until a green color change was noted (approximately 15 minutes).  The plate was 
gently tapped to ensure a homogenous distribution of  the colored product in each well.  The 
absorbance was measured at 405nm with a microplate reader (BioRad, Model 550), using the 
Mes#3, Ref#2 function.  The absorbance readout was analyzed against the standard CAT 
enzyme working dilution curve using Mac OS X Numbers. 
RESULTS
EXPORTIN 5 (XPO5) CAN MEDIATE TR NUCLEAR EXPORT
	 Prior experiments have shown that knockdown of  XPO5 slows TR shuttling  
(Subramanian, 2012), suggesting the XPO5 plays an important role in mediating CRM1-
independent nuclear export of  TR. To confirm and extend these findings, we determined 
whether XPO5 overexpression would change the nucleocytoplasmic distribution of  TR.  We 
hypothesized that XPO5 overexpression would shift the localization of  TR from the nucleus to 
the cytoplasm.  
First, we carried out control experiments to establish the distribution patterns for GFP-
TRα1, GRP-TRβ1, Myc, and the HA tag. Expression plasmids were transfected into HeLa cells, 
and the distribution of  the proteins was visualized by fluorescence microscopy, either directly for 
GFP-tagged proteins, or by indirect immunofluorescence with antibodies specific for Myc and 
HA (Figure 2).  As expected, the distribution of  both TRα1 and TRβ1 was primarily localized to 
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the nucleus (Bunn et al., 2001; Subramanian, 2012), with TRβ1 having a slightly greater 
cytosolic distribution than TRα1 (Baumann et al., 2001). The Myc and the HA tags showed a 
whole cell distribution.
Next, we transfected HeLa cells with expression plasmids for GFP-TR (α1 or β1), and 
either Myc-XPO5 or Myc as a control.  To visualize Myc-XPO5, the cells were immunostained 
with anti-Myc antibodies.  Cells that were successfully co-transfected were analyzed under the 
fluorescence microscope, and the TR distribution pattern was scored for a primarily nuclear, or 
nuclear and cytoplasmic distribution.  
 Consistent with our hypothesis, when XPO5 was overexpressed, TR shifted towards a 
significantly greater cytosolic distribution (p<0.001).  In the cells expressing GFP-TRα1 and Myc 
(control), 90.1% (±1.3%) of  cells showed a nuclear distribution TRα1, and 9.9% (±1.3%) of  cells  
showed a nuclear and cytosolic localization (Figure 3). When cells were expressing GFP-TRα1 
and Myc-XPO5, cells showed a 52.5% (±2.1%) nuclear distribution of  TRα1, and 48.5% 
(±2.1%) of  cells had a nuclear and cytosolic localization (Figure 3).  In the cells expressing GFP-
TRβ1 and Myc (control), 76.1% (±1.6%) of  cells had a nuclear distribution of  TRβ1, and 23.9% 
(±1.6%) of  cells had a nuclear and cytosolic localization (Figure 4). When cells were expressing 
GFP-TRβ1 and Myc-XPO5, 32.8% (±2.5%) of  cells had a nuclear distribution of  TRβ1, and 
67.2% (±2.5%) of  cells had a nuclear and cytosolic localization (Figure 4).  These overexpression 
experiments show that the distribution of  TR can change from the overexpression of  an export 
pathway.  In conclusion, for both TRα1 and TRβ1, overexpression of  XPO5 caused a significant 
increase in their cytosolic distribution, suggesting that XPO5 plays a key role in the export of  
TR. 
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Figure 2: Subcellular distribution of  GFP-TRα1, GFP-TRβ1, Myc, or HA
HeLa cells were transiently transfected with GFP-TRα1, GFP-TRβ1, Myc, or HA expression 
plasmids.  After approximately 24 hours the HeLa cells were fixed.  For visualizing Myc, cells 
were immunostained with anti-Myc primary and Goat Anti-Mouse IgG(H+L) secondary 
antibodies (red), before they were analyzed by fluorescence microscopy.  For visualizing HA, cells 
were immunostained with anti-HA primary and Texas Red Anti-Rabbit IgG(H+L) secondary 
antibodies (red), before they were analyzed by fluorescence microscopy.
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Figure 3: Overexpression of  XPO5 increases nuclear export of  TRα1
HeLa cells were transiently transfected with GFP-TRα1 expression plasmid and either Myc or 
Myc-XPO5 expression plasmids.  After approximately 24 hours the HeLa cells were fixed.  The 
cells were then immunostained with anti-Myc primary and Goat Anti-Mouse IgG(H+L) 
secondary antibodies (red), before they were analyzed by fluorescence microscopy.  GFP-TRα1 is 
visualized as green, while DAPI-stained nuclei are visualized as blue.  The bar graph summarizes 
the distribution of  GFP-TRα1 in HeLa cells, based on categories of  primarily nuclear (N), or 
nuclear and cytoplasmic (N+C).  Error bars are SEM, and the Chi-square test had a p-value < 
0.001 with four replicate experiments of  three slides each with at least 100 cells scored per slide.
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Figure 4: Overexpression of  XPO5 increases nuclear export of  TRβ1
Parallel experiments of  the GFP-TRα1 were conducted with GFP-TRβ1expression plasmid and 
either Myc or Myc-XPO5 expression plasmid.  The bar graph summarizes the GFP-TRβ1 
distribution of  the HeLa cells from overexpressing Myc-XPO5 based on categories of  primarily 
nuclear (N) or nuclear and cytoplasmic (N+C).  Error bars are SEM and the Chi-square test had 
a p-value < 0.001 with four replicate experiments of  three slides each with at least 100 cells 
scored per slide.
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OVEREXPRESSION OF XPO5 DECREASES TR-MEDIATED CAT REPORTER GENE 
EXPRESSION
 TR acts as a transcription factor for T3 responsive genes.  Since TR must be located 
within the nucleus to function as a transcription factor, we hypothesized that XPO5 
overexpression would reduce TR-mediated gene expression.  To further our understanding of  
XPO5 export, we used a CAT reporter gene under the positive control of  a TRE to examine the 
transcriptional activity of  GFP-TR (α1 or β1) (Figure 5). HeLa cells were transfected with 
expression plasmids for GFP-TR (α1 or β1), tk-TREpCAT reporter plasmid, and either Myc-
XPO5, or Myc as a control.  After 12 hour incubation with 100nM of  T3, whole cell lysates were 
used for CAT ELISAs to determine CAT protein levels.  When XPO5 was overexpressed in the 
presence of  T3, the CAT enzyme levels were dramatically lowered.  For TRα1, the amount of  
CAT protein produced without XPO5 overexpression was four times greater than when XPO5 
was overexpressed.  Similarly, for TRβ1 the amount of  CAT protein decreased by half  when 
XPO5 was overexpressed.  These CAT ELISA results support a model in which export of  TR 
provides an important level of  control for T3 responsive gene expression.  
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Figure 5: Overexpression of  XPO5 decreases TR-mediated CAT reporter gene 
expression
Myc or Myc-XPO5 expression plasmids, GFP-TR(α1 or β1) expression plasmids, and tk-TREp-
CAT reporter plasmids were overexpressed through transient transfection of  HeLa cells.  CAT 
ELISAs were conducted to measure CAT protein levels in whole cell extracts 12 hours after 
addition of  100nM T3.  Reporter gene expression (CAT protein) was measured in ng/mL (n=4).  
As a control, when GFP-TR (α1 or β1) expression plasmids were co-transfected with Myc-XPO5 
in the absence of  tk-TREp-CAT, there was no measurable CAT protein (data not shown).  The 
error bars in the bar chart represent SEMs.
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TR NUCLEAR EXPORT MEDIATED BY XPO5 REQUIRES NES-H12
 After demonstrating a role for XPO5 in TR nuclear export, we next examined which 
NES in TR is required for this export pathway, where each mutant includes a NES and a NLS.  
The two expression plasmids used in these experiments were GFP-GST-GFP-Hinge-
LBD(Δ269-410), which includes the Hinge region NLS, and the NES motifs located in helix 3 
and helix 6; and GFP-GST-GFP-Hinge-NESH12, which includes the Hinge NLS, and the NES 
located at helix 12 (Mavinakere et al., 2012).  We hypothesized that the effect of  XPO5 on TR 
export would be dependent on the presence of  one or the other NESs.  This hypothesis was 
tested using transient transfection assays in HeLa cells.  Expression plasmids of  either GFP-GST-
GFP-Hinge-LBD(Δ269-410) or GFP-GST-GFP-Hinge-NESH12 were co-transfected with either 
Myc-XPO5 or Myc.  To visualize the Myc-tagged proteins, the cells were immunostained with 
anti-Myc antibodies.  Cells that were successfully co-transfected were analyzed under the 
fluorescence microscope and the distribution of  the TR NES constructs was scored.  The NES 
constructs have an altered subcellular distribution compared with full length TRs; therefore, to 
reflect this difference constructs were scored into four categories: nuclear, nuclear greater than 
cytoplasmic, whole cell, and nuclear less than cytoplasmic.
 Consistent with our hypothesis of  the effect of  XPO5 being NES-specific, when XPO5 
was co-expressed with GFP-GST-GFP-Hinge-NESH12, there was a shift towards a more 
cytosolic distribution, whereas the distribution of  GFP-GST-GFP-Hinge-LBD(Δ269-410) with 
and without XPO5 was not statistically different (p<0.001) (Figures 6-7).  In the cells expressing 
GFP-GST-GFP-Hinge-LBD(Δ269-410) and Myc (control), 40.1% (±3.9%) of  cells had a whole 
distribution of  the NES-H3/H6 construct, and 59.9% (±3.9%) of  cells had a nuclear and 
cytosolic localization.  When cells were expressing GFP-GST-GFP-Hinge-LBD(Δ269-410) and 
Myc-XPO5, 0.8% (±0.41%) of  cells had a nuclear greater than cytoplasmic distribution of  the 
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NES-H3/H6 construct, 31.2% (±4.4%) of  cells had a whole cell distribution, and 68.0% 
(±4.8%) of  cells had a nuclear less than cytoplasmic localization (Figure 6). 
When cells were expressing GFP-GST-GFP-Hinge-NESH12 and Myc (control), 24.7% 
(±1.7%) of  cells showed a nuclear distribution of  the NES-H12 construct, 28.8% (±2.8%) of  
cells had a nuclear greater than cytoplasmic distribution, 44.9% (±3.2%) of  cells had a whole cell 
distribution, and 1.6% (±0.4%) of  cells had a nuclear less than cytosolic localization (Figure 7).  
In striking contrast, in the cells expressing GFP-GST-GFP-Hinge-NESH12 and Myc-XPO5, 
only 6.9% (±2.2%) of  cells had a nuclear distribution of  the NES-H12 construct, 10.8% (±2.5%) 
of  cells had nuclear greater than cytoplasmic distribution, 55.0% (±2.3%) of  cells had a whole 
cell distribution, and 27.4% (±3.7%) of  cells had nuclear less than cytosolic localization (Figure 
7).  This shift towards a more cytoplasmic distribution of  the NES-H12 construct when XPO5 is 
overexpressed suggests that to mediate nuclear export of  TR, XPO5 requires the NES located in 
helix 12.
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Figure 6: Overexpression of  XPO5 does not promote nuclear export of  TR via 
NES-H3/H6
Transient transfection experiments were conducted with GFP-GST-GFP-Hinge-LBD(Δ269-410) 
expression plasmid and either Myc or Myc-XPO5 expression plasmids.  The bar graph 
summarizes the distribution of  the NES-H3/H6 construct in HeLa cells overexpressing Myc-
XPO5 based on four categories: primarily nuclear (N), nuclear greater than cytoplasmic (N>C), 
whole cell (WC), or nuclear less than cytoplasmic (N<C).  Error bars are SEM and Chi-square 
had a p-value < 0.001 with four replicate experiments of  three slides each (100+ cells scored per 
slide).
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Figure 7: Overexpression of  XPO5 promotes nuclear export of  TR via NES-H12
Transient transfection experiments were conducted with GFP-GST-GFP-Hinge-NESH12 
expression plasmid and either Myc or Myc-XPO5 expression plasmids.  The bar graph 
summarizes the distribution of  the NES-H12 construct in HeLa cells overexpressing Myc-XPO5 
based on four categories: primarily nuclear (N), nuclear greater than cytoplasmic (N>C), whole 
cell (WC), or nuclear less than cytoplasmic (N<C).  Error bars are SEM and Chi-square had a p-
value < 0.001 with four replicate experiments of  three slides each (100+ cells scored per slide).
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RanBP17 CAN MEDIATE NUCLEAR EXPORT OF TRβ1 BUT NOT TRα1
 We examined the possible role of  RanBP17 as another alternative export pathway for TR 
based on the homology between RanBP17 and CRM1 (Koch et al., 2000).  We hypothesized that 
overexpression of  RanBP17 would shift the localization of  TR (α1 or β1) from the nucleus to the 
cytoplasm.  This hypothesis was tested by transfecting HeLa cells with expression plasmids for 
GFP-TR (α1 or β1), and either HA-RanBP17 or HA as a control.  To visualize the HA-tag, the 
cells were immunostained with anti-HA (primary) and Texas Red (secondary) antibodies.  Cells 
that were successfully co-transfected were analyzed under the fluorescence microscope, and 
scored for a primarily nuclear, or nuclear and cytoplasmic distribution of  TR.  
 Interestingly, RanBP17 overexpression did not promote nuclear export TRα1, but 
significantly enhanced nuclear export of  TRβ1 (p<0.001) (Figures 8-9).  Since less is known 
about TRβ1, it is possible that TRβ1 has different NES motifs compared with TRα1.  The HA-
tag expression plasmid itself  seemed to have some effect on TR distribution, thus controls of  only 
TRα1 or only TRβ1 were conducted as well.  When only TRα1 was transfected, 79.8% (±1.3%) 
of  cells had a nuclear distribution of  TRα1, and 20.2% (±1.3%) of  cells had a nuclear and 
cytosolic distribution.  In the cells expressing GFP-TRα1 and HA (control), there was a slight 
shift towards a more cytosolic distribution; 68.1% (±5.7%) of  cells had a nuclear distribution of  
TRα1, and 31.9% (±5.7%) of  cells had a nuclear and cytosolic localization (Figure 8).  When 
cells were co-expressing GFP-TRα1 and HA-RanBP17, the distribution was comparable to the 
HA tag-transfected cells; 65.4% (±4.4%) of  cells had a nuclear distribution of  TRα1, and 34.6% 
(±4.4%) of  cells had a nuclear and cytosolic localization (Figure 8).  
 In TRβ1-only transfections, 64.0% (±4.7%) of  cells had a nuclear distribution of  TRβ1, 
and 36.0% (±4.7) of  cells had a cytosolic distribution (Figure 9).  In the cells expressing GFP-
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Figure 8: Overexpression of  RanBP17 does not promote nuclear export of  TRα1
HeLa cells were transiently transfected with GFP-TRα1 expression plasmid and either HA or 
HA-RanBP17 expression plasmid.  After approximately 24 hours the HeLa cells were fixed.  The 
cells were then immunostained with anti-HA primary and Texas Red Anti-Rabbit IgG(H+L) 
secondary antibodies (red), before they were analyzed by fluorescence microscopy.  GFP-TRα1 is 
visualized as green, while DAPI-stained nuclei are visualized as blue.  The bar graph summarizes 
the distribution of  GFP-TRα1 in HeLa cells overexpressing RanBP17, based on categories of  
primarily nuclear (N) or nuclear and cytoplasmic (N+C).  Error bars are SEM and Chi-square 
had a p-value < 0.001 with three replicate experiments of  three slides each with at least 100 cells 
scored per slide.  
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Figure 9: Overexpression of  RanBP17 promotes nuclear export of  TRβ1
Parallel experiments were conducted with GFP-TRβ1 expression plasmid and either HA or HA-
RanBP17 expression plasmids.  The bar graph summarizes the distribution of  GFP-TRβ1 in 
HeLa cells overexpressing HA-RanBP17, based on categories of  primarily nuclear (N) or nuclear 
and cytoplasmic (N+C).  Error bars are SEM and Chi-square had a p-value < 0.001 with three 
replicate experiments of  three slides each with at least 100 cells scored per slide.
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TRβ1 and HA (control), there was a slight shift towards a more cytosolic distribution; 58.0%
(±1.6%) of  cells had a nuclear distribution of  TRβ1, and 42.0% (±1.6%) of  cells had a nuclear 
and cytosolic localization.  When cells were expressing GFP-TRβ1 and HA-RanBP17, there was 
a dramatic shift towards a more cytosolic distribution; only 21.8% (±4.9%) of  cells had a nuclear 
distribution of  TRβ1, while 78.3% (±2.8%) of  cells had a nuclear and cytosolic localization 
(Figure 9).  Taken together, these results suggest that TRβ1 nuclear export can be mediated by 
RanBP17; however, this export pathway is not available to TRα1.
OVEREXPRESSION OF RanBP17 REVEALS INCONCLUSIVE RESULTS 
CONCERNING TR-MEDIATED CAT REPORTER GENE EXPRESSION
 To further our understanding of  RanBP17 export, we thus used a CAT reporter gene 
under the positive control of  a TRE to examine the transcriptional activity of  GFP- TR (α1 or 
β1) (Figure 5).  HeLa cells were transfected with expression plasmids for GFP-TR (α1 or β1), tk-
TREpCAT reporter plasmid, and either HA-RanBP17, or HA as a control.  After 12 hour 
incubation with 100nM of  T3, whole cell lysates were used for CAT ELISAs to determine CAT 
protein levels.  When RanBP17 was overexpressed in the presence of  T3, very low levels of  the 
CAT enzyme levels were detected.  The amount of  protein quantified for both TRα1 or TRβ1 
was very low, and therefore conclusions cannot be made about RanBP17 mediated export of  TR.
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Figure 10: Low protein concentration reveals inconclusive results in 
overexpression of  RanBP17, TR, and TRE CAT experiments.  
HA or HA-RanBP17 expression plasmids, GFP-TR(α1 or β1) expression plasmids, and tk-
TREp-CAT reporter plasmids were overexpressed through transient transfection in HeLa cells.  
CAT ELISAs were conducted to measure CAT protein levels in whole cell extracts 12 hours after 
addition of  100nM T3.  Reporter gene expression (CAT protein) was measured in ng/mL (n=4).  
As a control, when GFP-TR(α1 or β1) expression plasmids were co-transfected with HA-
RanBP17 in the absence of  tk-TREp-CAT, there was no measured CAT protein (data not 
shown).  The error bars in the bar chart represent SEMs.  Overlapping error bars and overall low 
concentration of  CAT protein conclude inconclusive results.  
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DISCUSSION
 We have previously shown that TR can be exported from the nucleus through a CRM1-
dependent or CRM1-independent pathway (Grespin et al., 2008; Mavinakere et al., 2012).  We 
have also shown through RNA interference (RNAi) and fluorescence recovery after 
photobleaching (FRAP) that export of  TR is inhibited when XPO5 and exportin 7 (XPO7) are 
knocked down, suggesting that XPO5 and XPO7 are potential export pathways used by TR 
(Subramanian, 2012).  Here, we extended these findings to show that overexpression of  XPO5 
causes a shift in TR subcellular localization from the nucleus to the cytoplasm, which leads to a 
decrease in transcription of  a TR-mediated CAT reporter gene.  Using TR constructs with only 
one NES, we showed that XPO5 requires the helix 12 NES to mediate this shift in the subcellular 
localization of  TR to the cytoplasm. In contrast, XPO5 had no effect on the subcellular 
distribution pattern of  a construct containing the NES motif  located in the helix 3-helix 6 region 
of  TR.  We also investigated the role of  RanBP17 in TR nuclear export, as it shares homology 
with CRM1 and is most closely related to XPO7 (Koch et al., 2000).  Interestingly, we showed 
that overexpression of  RanBP17 causes a more cytosolic shift in the TRβ1 distribution, but has 
no impact on TRα1 localization.
XPO5 MEDIATES TR NUCLEAR EXPORT
	 CRM1 has been described as the general export factor for NRs, but CRM1-independent 
pathways have also been characterized.  TR has been shown previously to use a CRM1-
calreticulin cooperative pathway (Grespin et al., 2008), which is consistent with other NRs that 
can use the calreticulin pathway such as the glucocorticoid receptor (Holaska et al., 2001).  Over 
expression experiments and CAT ELISA assays supported the hypothesis that XPO5 is 
important in mediating the nuclear export pathway of  TR.  Taken together, prior RNAi 
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experiments (Subramanian, 2012) and the results reported here provide evidence that XPO5 is 
important in the TR nuclear export pathway.  Other known cargo for XPO5 includes tRNA, 
tRNA bound to eukaryotic elongation factor 1A, interleukin enhancer binding factor, microRNA, 
and double stranded RNA in a sequence independent manner (Calado et al., 2002; Brownawell 
and Macara, 2002; Yi et al., 2003; Bohnsack et al., 2004).  These results classify TR as a new 
cargo of  XPO5.  XPO5 was first seen to mediate AR nuclear export through in vitro export 
pathway assays, where the particular NES involved was not described (Shank et al., 2008).  A 
separate study by Saporita et al. (2003) describes a novel NES in ligand-binding-domain of  AR, 
which is CRM1-independent and insensitive to leptomycin B; however, no studies were done to 
see if  there was an interaction with this NES and XPO5.  Furthermore, Saporita et al. (2003) 
explained that steroid receptors lack leucine rich sequences as seen in a classical CRM1 NES, 
suggesting an evolutionarily link for why TR would have a nuclear export pathway facilitated by 
XPO5, as XPO5 also mediates the export of  the androgen receptor.  
XPO5 TRANSPORTS TR USING THE NES LOCATED AT HELIX 12
 The multiple NESs of  TR have been described as CRM1-dependent and CRM1-
independent.  Mutagenesis studies by Mavinakere et al. (2012) discovered two novel CRM1-
independent NESs located in TR either within helix 3, helix 6, or helix 12.  Since there exists 
more than one possible CRM1-independent NES, it was hypothesized that XPO5 would 
transport TR using one NES over another.  Through overexpression experiments, this hypothesis 
was supported.  There was a significant shift of  NES-H12-containing construct towards a greater 
cytosolic distribution.  However, there was no significant shift in distribution of  the NES-H3/H6-
containing construct.  These results suggest that XPO5 interacts either directly or indirectly with 
the NES in TR located in helix 12 of  the ligand-binding domain.  While less is known about 
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multiple export pathways used by one NR, the NLS-1 in the glucocorticoid receptor has been 
characterized to use three nuclear import pathways: importin α/β, importin 7, or importin 8 
(Pemberton and Paschal, 2005; Kumar et al., 2006).  Therefore, it is realistic to predict that other 
NRs with multiple NESs would use multiple nuclear export pathways.
A ROLE FOR RanBP17 IN TRβ1 NUCLEAR EXPORT
 RanBP17 is currently poorly characterized, except that is closely related to RanBP16/
XPO7 of  the importin-β superfamily (Koch et a., 2000) and shares sequence homology with 
CRM1 (Lee et al., 2010, Kutay, 2000).  Previous research with RNAi knockdown has shown that 
RanBP16/exportin-7 may play a role in mediating TR nuclear export (Subramanian, 2012).  
Given the homology with other exportins used by TR, RanBP17 was examined as a potential 
mediator of  TR nuclear export.  Overexpression experiments with TRα1/β1 and RanBP17 
expression plasmids revealed that RanBP17 promotes TRβ1 nuclear export, as seen through a 
shift towards a greater cytosolic distribution of  TRβ1 in the presence of  RanBP17.  However, 
RanBP17 had no effect on the subcellular distribution of  TRα1, and CAT ELISAs were 
inconclusive concerning RanBP17 as a possible export pathway for TR.  These results may be 
inconclusive due to a faulty microplate reader, which has since been replaced or the 
concentration of  CAT protein may be too little to be quantified.  Nevertheless, the distinction 
between differences in gene regulation of  the two isoforms (TRα1/β1) as seen through the cell 
fixation experiments could be due to differential distribution of  certain export pathways and 
isoforms (TRα1/TRβ1) throughout the body.  An example of  differential isoform distribution of  
TR is seen in Forrest et al. (2006), where double knockout TRβ mutant mice showed that only 
TRβ is necessary for the critical function of  the pituitary-thyroid axis.  
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SIGNIFICANCE
 Nuclear export of  TR has physiological effects on T3 controlled gene expression.  If  TR 
is not physically located in the nucleus, then gene expression cannot be turned off  or on.  When 
TR is in the nucleus, it can change gene expression without a ligand present, because TR can act 
as a transcription activator when bound to T3, but TR can also act as a transcription repressor 
when no ligand is bound (McKenna et al., 1999).  Furthermore, nuclear export is an important 
tool to understand TR regulation, because certain isoforms have been shown to have different 
roles when localized in the cytoplasm.  For example, TRβ has been seen to directly change gene 
expression of  transcription factor hypoxia-inducible factor alpha, while located in the cytoplasm 
(Moeller et al, 2006).  Additionally, TRα located in the cytoplasm can up regulate the synthesis 
proteins in cardiomyocytes by interacting with phosphatidyl-inositol 3-kinase (Davis et al., 2008). 
Davis et al. (2008) also speculated further non-genomic effects of  cytoplasmic TR in signal 
transduction pathways directed by thyroid hormone.  
 While post translational modifications are important in fine tuning gene expression in a 
cell, mislocalization can have wide reaching effects on disease, as seen in tissue areas of  high 
nuclear receptor activity, such as breast, ovary, pancreas, intestine, prostate, and lung (O’Malley 
and Kumar, 2009).  Specifically, when TR mislocalizes, resistance to thyroid hormone, changes in 
metabolism, and thyroid cancer can occur (Cheng et al., 2010).  Mislocalization of  TR has wide 
reaching effects, making the nuclear export pathways a key area of  research.  Further insight 
gained from the regulation of  nuclear export of  TR will ultimately enhance understanding of  the 
role of  TR in growth and development.
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CONCLUSIONS
 Our results show the ability of  TR to use a CRM1-independent pathway, and thus our 
data begin to encompass the complexity of  TR shuttling.  In conclusion, results presented here 
suggest that XPO5 can mediate TR nuclear export via the NES located in helix 12 of  the ligand 
binding domain. Further, RanBP17 may play a role in nuclear export of  TRβ1; however, 
replicate CAT ELISA experiments are required to confirm this finding.  Investigation of  the role 
of  other exportins, such as RanBP16/XPO7, is needed to fully characterize the multiple export 
pathways followed by TR. 
FUTURE DIRECTIONS
 CAT ELISA experiments with TR and RanBP17 need to be performed again; 
preliminary results were inconclusive.  If  RanBP17 causes a decrease in the amount of  TRβ1-
mediated CAT reporter gene expression, then these experiments will provide additional evidence 
for a role for RanBP17 in nuclear export.  Additionally, the effect of  RanBP17 on TR nuclear 
export has not been characterized through and fluorescence recovery after photobleaching 
(FRAP).  The shuttling kinetics can be measured through knockdown experiments with short 
hairpin RNA, to inhibit RanBP17, and followed by FRAP.  The ability for the photobleached 
nucleus to recover would denote to what extent the cell relies on RanBP17 for export of  TRβ1.
	 The sister exportin to RanBP17 is RanBP16, also known as XPO7.  Since these two 
exportins share homology, localization assays in the presence of  XPO7 should be considered for 
future research.  If  these experiments yield interesting export results, CAT ELISAs should also be 
performed to confirm TR export and the related effect on transcription quantitatively.  
	 Further XPO5 experiments should encompass protein-protein binding assays.  Our 
results suggest that XPO5 interacts with the NES located at helix 12; however, we have yet to 
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show how XPO5 interacts with the NES, whether directly or indirectly.  Pull-down assays and 
coimmunoprecipitation assays with XPO5, full-length TR, and NES constructs should be 
performed.  If  successful, these experiments will elucidate if  there is an indirect or direct binding 
between XPO5 and TR.
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